The markets opened flat with the Dow losing 9 points to 15,238 even as Standard & Poor's upgraded the credit outlook for the U. S. government from Negative to Stable. Nasdaq added 3 points to 3472.
On the upside
Apricus Biosciences (Nasdaq: APRI) received approval for its erectile dysfunction treatment Vitaros through the European Decentralized Procedure.
Shares of Rite Aid (NYSE: RAD) continued rising after forecasting first quarter earnings ahead of analyst expectations.
Macquarie upgraded Monsanto (NYSE: MON) from a Neutral rating to an Outperform rating.
On the downside
The Food and Drug Administration requested additional safety data for Dynavax Technologies' (Nasdaq: DVAX) hepatitis B vaccine HEPLISAV.
U. S. International Trade Commission judge David Shaw ruled that Netflix and Roku did not infringe on patents held by Rovi (Nasdaq: ROVI).
Jefferies downgraded Titan International (NYSE: TWI) from a Buy rating to a Hold rating.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 index soared 20 points to 1643.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here